Related Experiment Videos
[Uveitis associated with rifabutin treatment. Apropos of 3 patients]
G F Chevalley1, L Kaiser, N Bouchenaki
1Clinique universitaire d'ophtalmologie de Genève.
Klinische Monatsblatter Fur Augenheilkunde
|May 1, 1995
Abstract:
Disseminated Mycobacterium-avium complex (MAC) infection develops in most patients with AIDS. We report three cases of anterior uveitis with vitritis in AIDS patients treated by the combination of rifabutin, clarithromycin and ethambutol for MAC bacteremia. Uveitis secondary to the introduction of rifabutin treatment is suggested.
Insights
Disseminated Mycobacterium-avium complex (MAC) infection is common in AIDS patients. This study suggests rifabutin treatment may cause anterior uveitis and vitritis in these patients.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Immunology
Background:
- Disseminated Mycobacterium-avium complex (MAC) infection is a frequent opportunistic infection in patients with Acquired Immunodeficiency Syndrome (AIDS).
- Standard treatment regimens for MAC bacteremia often involve combinations of antibiotics.
Observation:
- Three cases of AIDS patients experiencing anterior uveitis and vitritis are presented.
- These patients were undergoing treatment for MAC bacteremia using a combination of rifabutin, clarithromycin, and ethambutol.
Findings:
- Anterior uveitis and vitritis developed during the course of rifabutin-containing therapy for MAC bacteremia.
- The temporal association suggests a potential causal link between rifabutin introduction and the onset of ocular inflammation.
Implications:
- Rifabutin, while crucial for treating MAC infection in AIDS, may pose a risk for developing specific ocular inflammatory conditions.
- Ophthalmologists and infectious disease specialists should be vigilant for uveitis in AIDS patients treated with rifabutin.
- Further investigation into the mechanism and incidence of rifabutin-induced uveitis is warranted.